Sign inJoin waitlistJoin the waitlist

Shuji Ogino

Chief, Program in Molecular Pathological Epidemiology · Harvard School of Public Health

Credentials: · · · · · ·

History

Program in Molecular Pathological Epidemiology Division · Harvard School of Public Health
Present
Harvard School of Public Health
Present
Harvard School of Public Health
Present

Molecular Genetic Pathology
2000–2001
Pathology
University of Pennsylvania Health System
1999–2000
Case Western Reserve University
1997–1999
Pathology
Allegheny General Hospital
1993–1997
Faculty of Medicine, The University of Tokyo
1989–1993

Research

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Genome Research · 2012 · 1,572 citations
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Nature · 2012 · 1,493 citations
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Science · 2017 · 1,247 citations

CF
Charles Fuchs
288 papers
Andrew Chan
281 papers
Mingyang Song
174 papers
Jeffrey Meyerhardt
169 papers
Jonathan Nowak
113 papers · 23 as a fellow
Marios Giannakis
95 papers · 2 as a fellow
Kimmie Ng
76 papers
DD
David Drew
39 papers
Robert Schoen
39 papers
AS
Annacarolina Fabiana Lucia Da Silva
38 papers · 32 as a resident
SG
Stephen Gruber
37 papers
MJ
Mark Jenkins
36 papers

Grants

Spatial Immunopathological Epidemiology of Colorectal Adenoma-Carcinoma Spectrum
National Cancer Institute · R01
Contact PI · $6.6M · Brigham and Women's Hospital
2020–2030
Accelerating Transdisciplinary Epidemiology of Colorectal Cancer
National Cancer Institute · R35
Contact PI · $6M · Brigham and Women's Hospital
2015–2022
Integrating Diet, Lifestyle and Tumor Tissue Molecular Subtyping to Study the Role of Adolescent Calcium Intake on the Risk of Early Onset Colorectal Neoplasia
National Cancer Institute · R21
PI · $427.4K · Harvard University d/b/a Harvard School of Public Health
2018–2021
The Third International Molecular Pathological Epidemiology (MPE) Meeting
National Cancer Institute · R13
Contact PI · $20K · Dana-Farber Cancer Inst
2016–2018